As of April 2020, Wim Tiest has joined InnoSer in the role of Chief Technology Officer (CTO) and as part of the company management team. Wim holds a MSc in biochemical engineering and in artificial intelligence, both from the KU Leuven. He has built his professional experience in life sciences during 28 years in various operational and managerial roles within GSK’s vaccine R&D and as an independent consultant. He is also an active member of the Belgian life science community and board member of

Wim will focus in his CTO role on new in-vivo and in-vitro models and their applications, support the conversion of innovation into commercial products and lead InnoSer into the era of digital workflow and big data.